NCT06735105Recruiting
Study on the Value of Three DWI Scanning Sequences in Staging of Gastric Cancer
Comparative Study on the Value of Three DWI Scan Sequences of 3.0T Magnetic Resonance in Staging of Gastric Cancer
Source: ClinicalTrials.gov · Last updated 16 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Accurate staging is critical for effective gastric cancer treatment planning. Conventional DWI (C-DWI) has limitations in image quality due to magnetic field inhomogeneity, which hampers precise T staging. This study aims to compare the image quality and T staging accuracy of C-DWI, TSE-DWI, and ZOOMit-DWI (Z-DWI) sequences in MRI examinations of gastric cancer patients. A prospective study plan to enroll 72 gastric cancer patients undergoing preoperative MRI with C-DWI, TSE-DWI, and Z-DWI sequences using a 3.0 T scanner. Quantitative metrics (ADC, SNR, CNR) and image quality were evaluated. T staging accuracy was assessed by comparing MRI results with postoperative pathological staging using ROC analysis.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 129 (estimated)
- First submitted
- 27 Nov 2024
- Start date
- 23 Dec 2023
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Yunnan Cancer Hospital
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06735105
What you commit to
- Study type: Interventional
- Planned participants: 129
- From 23 Dec 2023 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- The image quality cannot meet the diagnostic criteria;
- Patients could not tolerate MRI examination, resulting in incomplete MR-related sequence image data.
Who the study is looking for
- The patient was diagnosed with gastric cancer by pathological biopsy
- No biopsy was taken within 1 week before MR Examination to rule out the effect of bleeding on the image
- No contraindications for MRI examination; And exclude serious heart, liver, kidney, cerebrovascular diseases.
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yunnan Cancer Hospital Coordinator of this site? Confirm its status | Kunming | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.